PROFESSOR CHEZY BARENHOLZ

PROFESSOR CHEZY BARENHOLZ

Scientific Advisor

Head of the Laboratory of Membrane and Liposome Research at the Department of Biochemistry of the Hebrew University–Hadassah Medical School, Jerusalem, Israel. Professor Barenholz has 46 years experience in development R&D – Executive Editor of Progress in Lipid Research and the author of over 350 publications,  co-inventor of over 30 patent families, two of which underlie Doxil® for the treatment of breast and ovarian cancer (a doxorubicin remote-loaded sterically-stabilized ~100 nm liposome for treatment of cancer marketed by Johnson & Johnson). Granted various awards for outstanding contributions to the field of liposome science. A renowned specialist in biochemistry, biophysics, nanotechnology, and cancer. Received B.Sc., M.Sc. (cum laude) and Ph.D. degrees, all in Biochemistry, from the Hebrew University of Jerusalem, Israel.

DR. Joseph Pergolizzi

DR. Joseph Pergolizzi

Scientific Advisor

Dr. Pergolizzi has extensive academic, clinical, and business achievements related to his lifelong interest in advancing medical science and the practice of modern global healthcare.  He has gained a strong reputation as an experienced, results-oriented C-level leader with a particular focus on new companies.  He has held various C-level positions in private and public companies.  He can leverage his significant medical expertise, regulatory experience, and business skills to build a strong track record of success in many fields in the healthcare industry.  Dr. Pergolizzi is a Senior Partner at Naples Anesthesia and Pain Associates and serves as the Chief Operating Officer at NEMA Research Inc. He is a former subcommittee member of the FDA SUI and SGE VAH Grant Review for Analgesics and a Consultant to the National Pain Foundation Board of Directors.

ANTONIO BENITZ

ANTONIO BENITZ

Animal Health R&D Advisor

Global Head of R&D at Novartis Animal Health and VP R&D at Pfizer Animal Health. Former senior executive at Merial and Merck.

IZHAR SHAY

IZHAR SHAY

Advisor

Izhar Shay was the Minister of Science and Technology in the 35th Government of the State of Israel until January 2021. Before that, he managed the activities of Canaan Partners in Israel and led their investments in a variety of companies including LiveU, N-trig, Rollout.io, Drupe, Regulus and Prime Sense. Post his tenure in the government, Shay has been involved in innovative ventures which have the potential to make a significant impact . He is currently a venture partner with Disruptive AI, an early stage deep-tech VC focused on Artificial Intelligence investments. Shay is the Chairman of Kendago, a leading digital marketing group, and he is actively involved in a number of other innovative companies as an advisor, board member and mentor for CEOs and entrepreneurs.

DR. JOSEF GELDWERT

DR. JOSEF GELDWERT

Scientific Advisor

Clinical Instructor, Department of Orthopedics, Icahn School of Medicine at Mt. Sinai Medical Center in New York. Board Certified, American Board of Foot and Ankle Surgery, ABFAS. Fellow, American College of Foot and Ankle Surgeons. Fellow, American Academy of Podiatric Sports Medicine. Fellow, American Society of Podiatric Surgeons. Co-Medical Director, NYC Triathlon.

 DR. MITCHELL KLINE

DR. MITCHELL KLINE

Scientific Advisor

Dr. Mitchell Kline is a board-certified, fellowship-trained surgical and clinical dermatologist, currently acting as the Principal Clinician at Kline Dermatology and the Clinical Assistant Instructor of Dermatology at Weill Cornell Medical College. He has published over ten articles, holds 23 organizational memberships, has generated five research and concept proposals, and has participated in over 14 grand rounds presentations.